Welcome!

News Feed Item

Coronary Thrombosis Global Clinical Trials Review, H2, 2014

LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Coronary Thrombosis Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/652973/Coronary-Thrombosis-Global-Clinical-Trials-Review-H2-2014.html

Coronary Thrombosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Coronary Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Coronary Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

List of Tables 3
List of Figures 4
Introduction 5
Coronary Thrombosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Coronary Thrombosis 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Drugs 23
Clinical Trial Overview of Top Institutes / Government 24
Hopital de la Timone 24
Clinical Trial Overview of Hopital de la Timone 24
Fujian Provincial Hospital 25
Clinical Trial Overview of Fujian Provincial Hospital 25
Herz-Zentrum Bad Krozingen 26
Clinical Trial Overview of Herz-Zentrum Bad Krozingen 26
University of Zurich 27
Clinical Trial Overview of University of Zurich 27
NHS Greater Glasgow and Clyde 28
Clinical Trial Overview of NHS Greater Glasgow and Clyde 28
Samsung Medical Center 29
Clinical Trial Overview of Samsung Medical Center 29
Hamilton Health Sciences 30
Clinical Trial Overview of Hamilton Health Sciences 30
Odense University Hospital 31
Clinical Trial Overview of Odense University Hospital 31
Universitaire Ziekenhuizen Leuven 32
Clinical Trial Overview of Universitaire Ziekenhuizen Leuven 32
Assistance Publique - Hopitaux de Paris 33
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 33
Five Key Clinical Profiles 34
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Disclaimer 53
Source 53

List of Tables
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Coronary Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 15
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Coronary Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Coronary Thrombosis Therapeutics, Global, Terminated Clinical Trials, 2014* 20
Coronary Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Coronary Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopital de la Timone, 2014* 24
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fujian Provincial Hospital, 2014* 25
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Herz-Zentrum Bad Krozingen, 2014* 26
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014* 27
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Greater Glasgow and Clyde, 2014* 28
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 29
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014* 30
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014* 31
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2014* 32
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 33

List of Figures
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 15
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Coronary Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
GlobalData Methodology 52

Read the full report:
Coronary Thrombosis Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/652973/Coronary-Thrombosis-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Cloud computing is being adopted in one form or another by 94% of enterprises today. Tens of billions of new devices are being connected to The Internet of Things. And Big Data is driving this bus. An exponential increase is expected in the amount of information being processed, managed, analyzed, and acted upon by enterprise IT. This amazing is not part of some distant future - it is happening today. One report shows a 650% increase in enterprise data by 2020. Other estimates are even higher....
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
The 19th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Digital Transformation, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportuni...
Identity is in everything and customers are looking to their providers to ensure the security of their identities, transactions and data. With the increased reliance on cloud-based services, service providers must build security and trust into their offerings, adding value to customers and improving the user experience. Making identity, security and privacy easy for customers provides a unique advantage over the competition.
Qosmos has announced new milestones in the detection of encrypted traffic and in protocol signature coverage. Qosmos latest software can accurately classify traffic encrypted with SSL/TLS (e.g., Google, Facebook, WhatsApp), P2P traffic (e.g., BitTorrent, MuTorrent, Vuze), and Skype, while preserving the privacy of communication content. These new classification techniques mean that traffic optimization, policy enforcement, and user experience are largely unaffected by encryption. In respect wit...
Fact: storage performance problems have only gotten more complicated, as applications not only have become largely virtualized, but also have moved to cloud-based infrastructures. Storage performance in virtualized environments isn’t just about IOPS anymore. Instead, you need to guarantee performance for individual VMs, helping applications maintain performance as the number of VMs continues to go up in real time. In his session at Cloud Expo, Dhiraj Sehgal, Product and Marketing at Tintri, wil...
19th Cloud Expo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterpri...
Enterprises have forever faced challenges surrounding the sharing of their intellectual property. Emerging cloud adoption has made it more compelling for enterprises to digitize their content, making them available over a wide variety of devices across the Internet. In his session at 19th Cloud Expo, Santosh Ahuja, Director of Architecture at Impiger Technologies, will introduce various mechanisms provided by cloud service providers today to manage and share digital content in a secure manner....
Smart Cities are here to stay, but for their promise to be delivered, the data they produce must not be put in new siloes. In his session at @ThingsExpo, Mathias Herberts, Co-founder and CTO of Cityzen Data, will deep dive into best practices that will ensure a successful smart city journey.
SYS-CON Events announced today that 910Telecom will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Housed in the classic Denver Gas & Electric Building, 910 15th St., 910Telecom is a carrier-neutral telecom hotel located in the heart of Denver. Adjacent to CenturyLink, AT&T, and Denver Main, 910Telecom offers connectivity to all major carriers, Internet service providers, Internet backbones and ...
To leverage Continuous Delivery, enterprises must consider impacts that span functional silos, as well as applications that touch older, slower moving components. Managing the many dependencies can cause slowdowns. See how to achieve continuous delivery in the enterprise.
There is growing need for data-driven applications and the need for digital platforms to build these apps. In his session at 19th Cloud Expo, Muddu Sudhakar, VP and GM of Security & IoT at Splunk, will cover different PaaS solutions and Big Data platforms that are available to build applications. In addition, AI and machine learning are creating new requirements that developers need in the building of next-gen apps. The next-generation digital platforms have some of the past platform needs a...
SYS-CON Events announced today Telecom Reseller has been named “Media Sponsor” of SYS-CON's 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Telecom Reseller reports on Unified Communications, UCaaS, BPaaS for enterprise and SMBs. They report extensively on both customer premises based solutions such as IP-PBX as well as cloud based and hosted platforms.
DevOps at Cloud Expo – being held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Am...
I wanted to gather all of my Internet of Things (IOT) blogs into a single blog (that I could later use with my University of San Francisco (USF) Big Data “MBA” course). However as I started to pull these blogs together, I realized that my IOT discussion lacked a vision; it lacked an end point towards which an organization could drive their IOT envisioning, proof of value, app dev, data engineering and data science efforts. And I think that the IOT end point is really quite simple…